关注
Jeffrey Bluestone
Jeffrey Bluestone
Sonoma Biotherapeutics
在 ucsf.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
CD28/B7 system of T cell costimulation
DJ Lenschow, TL Walunas, JA Bluestone
Annual review of immunology 14 (1), 233-258, 1996
37261996
Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4
EA Tivol, F Borriello, AN Schweitzer, WP Lynch, JA Bluestone, AH Sharpe
Immunity 3 (5), 541-547, 1995
36631995
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
W Liu, AL Putnam, Z Xu-Yu, GL Szot, MR Lee, S Zhu, PA Gottlieb, ...
The Journal of experimental medicine 203 (7), 1701-1711, 2006
35042006
CTLA-4 can function as a negative regulator of T cell activation
TL Walunas, DJ Lenschow, CY Bakker, PS Linsley, GJ Freeman, ...
Immunity 1 (5), 405-413, 1994
27871994
B7/CD28 costimulation is essential for the homeostasis of the CD4+ CD25+ immunoregulatory T cells that control autoimmune diabetes
B Salomon, DJ Lenschow, L Rhee, N Ashourian, B Singh, A Sharpe, ...
Immunity 12 (4), 431-440, 2000
26362000
International trial of the Edmonton protocol for islet transplantation
AMJ Shapiro, C Ricordi, BJ Hering, H Auchincloss, R Lindblad, ...
New England Journal of Medicine 355 (13), 1318-1330, 2006
24942006
Innate immunity and intestinal microbiota in the development of Type 1 diabetes
L Wen, RE Ley, PY Volchkov, PB Stranges, L Avanesyan, AC Stonebraker, ...
Nature 455 (7216), 1109-1113, 2008
22432008
Identification of a monoclonal antibody specific for a murine T3 polypeptide.
O Leo, M Foo, DH Sachs, LE Samelson, JA Bluestone
Proceedings of the National Academy of Sciences 84 (5), 1374-1378, 1987
20911987
Natural versus adaptive regulatory T cells
JA Bluestone, AK Abbas
Nature Reviews Immunology 3 (3), 253-257, 2003
20202003
The B7 and CD28 receptor families
CH June, JA Bluestone, LM Nadler, CB Thompson
Immunology today 15 (7), 321-331, 1994
17941994
Genetics, pathogenesis and clinical interventions in type 1 diabetes
JA Bluestone, K Herold, G Eisenbarth
Nature 464 (7293), 1293-1300, 2010
16052010
Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg
DJ Lenschow, Y Zeng, JR Thistlethwaite, A Montag, W Brady, MG Gibson, ...
Science 257 (5071), 789-792, 1992
14831992
Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo
X Zhou, SL Bailey-Bucktrout, LT Jeker, C Penaranda, ...
Nature immunology 10 (9), 1000-1007, 2009
14812009
In vitro–expanded antigen-specific regulatory T cells suppress autoimmune diabetes
Q Tang, KJ Henriksen, M Bi, EB Finger, G Szot, J Ye, EL Masteller, ...
The Journal of experimental medicine 199 (11), 1455-1465, 2004
14802004
Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus
KC Herold, W Hagopian, JA Auger, E Poumian-Ruiz, L Taylor, ...
New England Journal of Medicine 346 (22), 1692-1698, 2002
14682002
Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation
B Salomon, JA Bluestone
Annual review of immunology 19 (1), 225-252, 2001
14082001
The NOD mouse: a model of immune dysregulation
MS Anderson, JA Bluestone
Annu. Rev. Immunol. 23 (1), 447-485, 2005
14012005
The Foxp3+ regulatory T cell: a jack of all trades, master of regulation
Q Tang, JA Bluestone
Nature immunology 9 (3), 239-244, 2008
13772008
Control of peripheral T‐cell tolerance and autoimmunity via the CTLA‐4 and PD‐1 pathways
BT Fife, JA Bluestone
Immunological reviews 224 (1), 166-182, 2008
12452008
Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis
N Komatsu, K Okamoto, S Sawa, T Nakashima, M Oh-Hora, T Kodama, ...
Nature medicine 20 (1), 62-68, 2014
12032014
系统目前无法执行此操作,请稍后再试。
文章 1–20